Aproximación clínica de la toma de decisiones sobre fertilidad en pacientes de cáncer de mama

Erreferentzia bibliografikoak

• 1. Hankey BF, Miller B, Curtis R, Kosary C. Trends in breast cancer in younger women in contrast to older women. J Natl Cancer Inst Monogr 1994; 16:7-14.
• 1. Dunn L, Fox KR. Techniques for fertility preservation in patients with breast cancer. Curr Opin Obstet Gynecol 2009; 21(1):68-73.
• 2. Kroman N, Jensen MB, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M. Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 2000; 320(7233):474-8.
• 3. Omne-Pontén M, Holmberg L, Sjödén PO. Psychosocial adjustment among women with breast cancer stages I and II: Six-year follow-up of consecutive patients. J Clin Oncol 1994; 12(9):1778-82.
• 4. Kroenke CH, Kubzansky LD, Schernhammer ES, Holmes MD, Kawachi I. Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol 2006; 24(7):1105-11.
• 5. Gelber S, Coates AS, Goldhirsch A, Castiglione-Gertsch M, Marini G, Lindtner J, et al. Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol 2001; 19(6):1671-5.
• 6. Patrizio P, Butts S, Caplan A. Ovarian tissue preservation and future fertility: emerging technologies and ethical considerations. J Natl Cancer Inst Monogr 2005; (34): 107-10.
• 7. Robertson JA. Cancer and fertility preservation. J Natl Cancer Inst Monogr 2005; (34): 104-6.
• 8. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996; 14(5):1718-29.
• 9. Castiglione-Gertsch M, O’Neill A, Price KN, Goldhirsch A, Coates AS, Colleoni M, et al. Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial. J Natl Cancer Inst 95(24): 1833-46.
• 10. Roché H, Kerbrat P, Bonneterre J, Fargeot P, Fumoleau P, Monnier A, et al. Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French adjuvant study Group 06 randomized trial. Ann Oncol 2006; 17(8):1221-7.
• 11. Nabholtz JM, Reese D, Lindsay MA, Riva A. Evidence for the use of chemotherapy in breast cancer. Int J Clin Oncol 2002; 7(4):254-64.
• 12. Martin M, Pienkowski T, Mackey J, Pawlicki M, Guastalla JP, Weaver C, et al. Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 2005; 352 (22): 2302-13.
• 13. Demeestere I, Simon P, Englert Y, Delbaere A. Preliminary experience of ovarian tissue cryopreservation procedure: alternatives, perspectives and feasibility. Reprod Biomed Online 2003; 7(5):572-9.
• 14. Brincker H, Rose C, Rank F, Mouridsen HT, Jakobsen A, Dombernowsky P, et al. Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer. J Clin Oncol 1987; 5(11):1771-8.
• 15. Pagani O, O’Neill A, Castiglione M, Gelber RD, Goldhirsch A, Rudenstam etm al. Prognostic impact of amenorrhea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: Results of the International Breast Cancer Study Group (IBCSG) Trial VI. Eur J Cancer 1998; 34(5):632-40.
• 16. Goodwin PJ, Ennis M, Pritchard KI, Trudeau M, Hood N. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 1999; 17(8):2365-70.
• 17. Fumoleau P, Kerbrat P, Romestaing P, Fargeot P, Brémond A, Namer M, et al. Randomized trial comparing six versus three cycles of epirubicin-based adjuvant chemotherapy in premenopausal, node-positive breast cancer patients: 10-year follow-up results of the French Adjuvant Study Group 01 trial. J Clin Oncol 2003; 21(2):298-305.
• 18. Pérez-Fidalgo JA, Roselló S, García-Garré E, Jordá E, Martín-Martorell P, Bermejo B, et al. Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens. Breast Cancer Res Treat 2010; 120(1):245-51.
• 19. Sonmezer M, Oktay K. Fertility preservation in young women undergoing breast cancer therapy. Oncologist. 2006; 11(5):422-34.
• 20. Bankowski BJ, Lyerly AD, Faden RR, Wallach EE. The social implications of embryo cryopreservation. Fertil Steril 2005; 84(4):823-32.
• 21. Kim SS. Fertility preservation in female cancer patients: current developments and future directions. Fertil Steril 2006; 85(1):1-11.
• 22. Pelinck MJ, Hoek A, Simons AH, Heineman MJ. Efficacy of natural cycle IVF: a review of the literature. Hum Reprod Update. 2002; 8(2):129-39.
• 23. Casper RF. Aromatase inhibitors in ovarian stimulation. J Steroid Biochem Mol Biol 2007; 106(1-5):71-5.
• 24. Novella-Mestre E, Sanchez M. Estado actual de la congelación de la corteza ovarica. En: García Velasco JA, editor Cuadernos de Medicina Reproductiva 2009. p. 83-90.
• 25. Donnez J, Jadoul P, Squifflet J, Van Langendonckt A, Donnez O, Van Eyck AS, et al. Ovarian tissue cryopreservation and transplantation in cancer patients. Best Pract Res Clin Obstet Gynaecol 2010; 24(1):87-100.
• 26. Pal SK, Hurria A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol 2010; 28(26):4086-93.
• 27. Quinn GP, Vadaparampil ST, Lee JH, Jacobsen PB, Bepler G, Lancaster J, et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol 2009; 27(35):5952-7.
• 28. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006; 24(18):2917-31.
• 29. Thewes B. Meiser A. Taylor, K.A. Phillips S. Pendlebury A. Capp D. et al. Fertility and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol 2005; 23:5155-65.
• 30. Partridge AH. Fertility preservation: a vital survivorship issue for young women with breast cancer. J Clin Oncol 2008; 26(16):2612-3.
• 31. Partridge AH, Winer EP. Fertility after breast cancer: questions abound. J Clin Oncol 2005; 23(19):4259-61.
• 32. Dudzinski DM. Ethical issues in fertility preservation for adolescent cancer survivors: oocyte and ovarian tissue cryopreservation. J Pediatr Adolesc Gynecol. 2004; 17(2):97-102.
• 33. Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP. SPIKES-A six-step protocol for delivering bad news: Application to the patient with cancer. Oncologist. 2000; 5(4):302-11.
• 34. Buckman R. How to break bad news. A guide for health care professionals. Baltimore: Ed. John Hopkins, 1992.
• 35. Labrador FJ, Barea E. La información del diagnóstico a pacientes de cáncer. Psicooncología 2004; 1:51-66.
• 36. Sáez-Mansilla C, Costa-Ferrer R, CarmonaSaborido L, Sáez T, Pellicer A. Sánchez M. Infertility and cancer in young women. Psychological features. Fertil Steril 2009; 92(3):185.